University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Roulstone, V"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 10.

Article

Roulstone, V, Pedersen, M, Kyula, J, Mansfield, D, Khan, AA, McEntee, G, Wilkinson, M, Karapanagiotou, E, Coffey, M, Marais, R, Jebar, A, Errington-Mais, F, Melcher, A, Vile, R, Pandha, H, McLaughlin, M and Harrington, KJ (2015) BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress MOLECULAR THERAPY, 23 (5). pp. 931-942.

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

Kyula, JN, Khan, AA, Mansfield, D, Karapanagiotou, EM, Mclaughlin, M, Roulstone, V, Zaidi, S, Pencavel, T, Touchefeu, Y, Seth, R, Chen, NG, Yu, YA, Zhang, Q, Melcher, AA, Vile, RG, Pandha, HS, Ajaz, M, Szalay, AA and Harrington, KJ (2014) Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling Oncogene, 33 (13). pp. 1700-1712.

Mansfield, D, Pencavel, T, Kyula, JN, Zaidi, S, Roulstone, V, Thway, K, Karapanagiotou, L, Khan, AA, McLaughlin, M, Touchefeu, Y, Seth, R, Melcher, AA, Vile, RG, Pandha, HS and Harrington, KJ (2012) Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral Oncol.

Roulstone, V, Twigger, K, Zaidi, S, Pencavel, T, Kyula, JN, White, C, McLaughlin, M, Seth, R, Karapanagiotou, EM, Mansfield, D, Coffey, M, Nuovo, G, Vile, RG, Pandha, HS, Melcher, AA and Harrington, KJ (2012) Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther.

Adair, RA, Roulstone, V, Scott, KJ, Morgan, R, Nuovo, GJ, Fuller, M, Beirne, D, West, EJ, Jennings, VA, Rose, A, Kyula, J, Fraser, S, Dave, R, Anthoney, DA, Merrick, A, Prestwich, R, Aldouri, A, Donnelly, O, Pandha, H, Coffey, M, Selby, P, Vile, R, Toogood, G, Harrington, K and Melcher, AA (2012) Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci Transl Med, 4 (138).

Karapanagiotou, EM, Roulstone, V, Twigger, K, Ball, M, Tanay, M, Nutting, C, Newbold, K, Gore, ME, Larkin, J, Syrigos, KN, Coffey, M, Thompson, B, Mettinger, K, Vile, RG, Pandha, HS, Hall, GD, Melcher, AA, Chester, J and Harrington, KJ (2012) Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies CLINICAL CANCER RESEARCH, 18 (7). pp. 2080-2089.

Twigger, K, Roulstone, V, Kyula, J, Karapanagiotou, EM, Syrigos, KN, Morgan, R, White, C, Bhide, S, Nuovo, G, Coffey, M, Thompson, B, Jebar, A, Errington, F, Melcher, AA, Vile, RG, Pandha, HS and Harrington, KJ (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer, 12.

Comins, C, Spicer, J, Protheroe, A, Roulstone, V, Twigger, K, White, CM, Vile, R, Melcher, A, Coffey, MC, Mettinger, KL, Nuovo, G, Cohn, DE, Phelps, M, Harrington, KJ and Pandha, HS (2010) REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer CLINICAL CANCER RESEARCH, 16 (22). pp. 5564-5572.

Harrington, KJ, Karapanagiotou, EM, Roulstone, V, Twigger, KR, White, CL, Vidal, L, Beirne, D, Prestwich, R, Newbold, K, Ahmed, M, Thway, K, Nutting, CM, Coffey, M, Harris, D, Vile, RG, Pandha, HS, DeBono, JS and Melcher, AA (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077.

This list was generated on Tue Sep 26 18:27:15 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800